Can the Nephrologist Prevent Dialysis-Related Amyloidosis?
- 1 July 1991
- journal article
- review article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 18 (1) , 1-11
- https://doi.org/10.1016/s0272-6386(12)80283-6
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- β-2-Microglobulin and Main Granulocyte Components in Hemodialysis PatientsArtificial Organs, 1989
- Different Handling of Beta2-Microglobulin during Hemodialysis and HemofiltrationNephron, 1988
- Inhibitory effects of β2-microglobulin on invitro calcification of osteoblastic cellsBiochemical and Biophysical Research Communications, 1986
- HAEMODIALYSIS MEMBRANES, SERUM β2-MICROGLOBULIN, AND DIALYSIS AMYLOIDOSISThe Lancet, 1986
- In vitro formation of amyloid fibrils from intact β2-microglobulinBiochemical and Biophysical Research Communications, 1985
- Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole bloodKidney International, 1985
- A new form of amyloid protein associated with chronic hemodialysis was identified as β2-microglobulinBiochemical and Biophysical Research Communications, 1985
- Interleukin-1 and the Pathogenesis of the Acute-Phase ResponseNew England Journal of Medicine, 1984
- Complement Activation and Hypersensitivity Reactions to Dialysis MembranesNew England Journal of Medicine, 1984
- Serum β2-Microglobulin in Hemodialyzed PatientsNephron, 1978